| Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus SJ Rozzo, JD Allard, D Choubey, TJ Vyse, S Izui, G Peltz, BL Kotzin Immunity 15 (3), 435-443, 2001 | 434 | 2001 |
| Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: results from an open-label extension study for … K Gordon, K Papp, Y Poulin, Y Gu, S Rozzo, EH Sasso Journal of the American Academy of Dermatology 66 (2), 241-251, 2012 | 215 | 2012 |
| Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire SA Johnson, SJ Rozzo, JC Cambier The Journal of Immunology 168 (10), 5014-5023, 2002 | 174 | 2002 |
| Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. CG Drake, SJ Rozzo, HF Hirschfeld, NP Smarnworawong, ED Palmer, ... Journal of immunology (Baltimore, Md.: 1950) 154 (5), 2441-2447, 1995 | 169 | 1995 |
| Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice. TJ Vyse, SJ Rozzo, CG Drake, S Izui, BL Kotzin Journal of immunology (Baltimore, Md.: 1950) 158 (11), 5566-5574, 1997 | 158 | 1997 |
| Effect of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis SJ Rozzo, TJ Vyse, CG Drake, BL Kotzin Proceedings of the National Academy of Sciences 93 (26), 15164-15168, 1996 | 153 | 1996 |
| Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2 … K Reich, RB Warren, L Iversen, L Puig, I Pau‐Charles, A Igarashi, ... British Journal of Dermatology 182 (3), 605-617, 2020 | 140 | 2020 |
| Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. TJ Vyse, CG Drake, SJ Rozzo, E Roper, S Izui, BL Kotzin The Journal of clinical investigation 98 (8), 1762-1772, 1996 | 129 | 1996 |
| Homeostatically proliferating CD4+ T cells are involved in the pathogenesis of an Omenn syndrome murine model K Khiong, M Murakami, C Kitabayashi, N Ueda, S Sawa, A Sakamoto, ... The Journal of clinical investigation 117 (5), 1270-1281, 2007 | 83 | 2007 |
| Purification of transfer factors SJ Rozzo, CH Kirkpatrick Molecular immunology 29 (2), 167-182, 1992 | 81 | 1992 |
| Development of murine lupus involves the combined genetic contribution of the SLAM and FcγR intervals within the Nba2 autoimmune susceptibility locus TN Jørgensen, J Alfaro, HL Enriquez, C Jiang, WM Loo, S Atencio, ... The journal of immunology 184 (2), 775-786, 2010 | 79 | 2010 |
| The long-term safety of adalimumab treatment in moderate to severe psoriasis: a comprehensive analysis of all adalimumab exposure in all clinical trials C Leonardi, K Papp, B Strober, K Reich, A Asahina, Y Gu, J Beason, ... American journal of clinical dermatology 12, 321-337, 2011 | 78 | 2011 |
| Genetic Contributions to Lupus‐like Disease in (NZB×NZW)F1 Mice CG Drake, SJ ROZZO, TJ Vyse, E Palmer, BL Kotzin Immunological reviews 144 (1), 51-74, 1995 | 78 | 1995 |
| Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials … D Thaci, S Piaserico, RB Warren, AK Gupta, W Cantrell, Z Draelos, ... British Journal of Dermatology 185 (2), 323-334, 2021 | 67 | 2021 |
| Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis S Kikuchi, L Fossati-Jimack, T Moll, H Amano, E Amano, A Ida, ... The Journal of Immunology 174 (2), 1111-1117, 2005 | 65 | 2005 |
| Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus. SJ Rozzo, CG Drake, BL Chiang, ME Gershwin, BL Kotzin Journal of immunology (Baltimore, Md.: 1950) 153 (3), 1340-1351, 1994 | 61 | 1994 |
| Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus H Amano, E Amano, ML Santiago‐Raber, T Moll, E Martinez‐Soria, ... Arthritis & Rheumatism 52 (9), 2790-2798, 2005 | 57 | 2005 |
| Contributions of Eaz and Ebz MHC genes to lupus susceptibility in New Zealand mice TJ Vyse, SJ Rozzo, CG Drake, VB Appel, M Lemeur, S Izui, E Palmer, ... The Journal of Immunology 160 (6), 2757-2766, 1998 | 57 | 1998 |
| Generation and characterization of cloned T helper cell lines for anti-DNA responses in NZB. H-2bm12 mice. M Naiki, BL Chiang, D Cawley, A Ansari, SJ Rozzo, BL Kotzin, A Zlotnik, ... Journal of immunology (Baltimore, Md.: 1950) 149 (12), 4109-4115, 1992 | 57 | 1992 |
| Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study PJ Mease, S Chohan, FJG Fructuoso, ME Luggen, P Rahman, ... Annals of the rheumatic diseases 80 (9), 1147-1157, 2021 | 56 | 2021 |
